Introduction
Actemra IV Infusion 80 mg/4 ml, also known as Actemra and RoActemra, is an interleukin-6 (IL-6) antagonist monoclonal antibody prescribed for the treatment of rheumatoid arthritis and giant cell arteritis. The mAb is approved by the US Food and Drug administration and is commercially available in Europe, U.S.A, Japan, and India.Uses
Actemra IV Infusion 80 mg/4 ml is used to treat adults with moderate to severe rheumatoid arthritis (RA) who have received one or more disease-modifying antirheumatic drugs (DMARDs) such as methotrexate. It is also used to treat active systemic juvenile idiopathic arthritis (SJIA) in children 2 years of age and older.Mechanism of Action
Actemra IV Infusion 80 mg/4 ml is a monoclonal antibody which binds to and neutralizes interleukin-6 (IL-6) and blocks its action on cells. IL-6 is a pro-inflammatory cytokine associated with inflammation and destruction of joint tissues in RA. Blockade of IL-6 activity reduces inflammation and preserves joint tissue.How Long Does It Take to Work?
The onset of action of tocilizumab occurs 5–10 days after the first dose and is usually experienced within 4–6 weeks of initial treatment.Absorption
Actemra IV Infusion 80 mg/4 ml is administered intravenously and is generally well absorbed into the bloodstream.Route of Elimination
Actemra IV Infusion 80 mg/4 ml is cleared from the body by the kidneys, and metabolites are excreted in urine.Dosage
The usual starting dose of tocilizumab is 162 mg every other week, given as an intravenous infusion over 1 hour. In rheumatoid arthritis, after six months of treatment, dose may be increased up to 324 mg every other week (or 8 mg/kg every other week or 4 mg/kg every week). In systemic juvenile idiopathic arthritis, dose may be increased to 248 mg every week.Administration
Actemra IV Infusion 80 mg/4 ml is administered intravenously and is generally well absorbed into the bloodstream.Side Effects
The most common side effects of tocilizumab include headache, fever, cough, nausea, abdominal pain, rash, and fatigue. More serious side effects may include increased risk of infections, stroke , blood clots, and liver damage.Toxicity
The toxic effects of tocilizumab can occur at any dose of therapy. The most commonly seen problems are allergic reactions, acute infusion reactions, and cytopenias.Precautions
Actemra IV Infusion 80 mg/4 ml should be used with caution in patients with a history of infections, stroke, or liver impairment.Interaction
Actemra IV Infusion 80 mg/4 ml has the potential to interact with several drugs such as methotrexate, leflunomide, corticosteroids, non-steroidal anti-inflammatory drugs, and warfarin.Disease Interaction
Actemra IV Infusion 80 mg/4 ml may interact with other underlying diseases such as hepatitis B, hepatitis C, tuberculosis, and congestive heart failure.Drug Interaction
Actemra IV Infusion 80 mg/4 ml has the potential to interact with several drugs such as methotrexate, leflunomide, corticosteroids, non-steroidal anti-inflammatory drugs, and warfarin.Food Interaction
Actemra IV Infusion 80 mg/4 ml has no known specific food interactions.Pregnancy Use
Actemra IV Infusion 80 mg/4 ml should be used with caution in pregnant women.Lactation Use
Actemra IV Infusion 80 mg/4 ml should not be used in breastfeeding women.Acute Overdose
An acute overdose of tocilizumab can cause increased risk of infection, bleeding, or liver damage.Contraindication
Actemra IV Infusion 80 mg/4 ml should not be used in cases of hypersensitivity or allergy to the drug.Use Direction
Actemra IV Infusion 80 mg/4 ml must be administered as an intravenous infusion over 1 hour. The usual starting dose of tocilizumab is 162 mg every other week. In rheumatoid arthritis, after six months of treatment, dose may be increased up to 324 mg every other week (or 8 mg/kg every other week or 4 mg/kg every week). In systemic juvenile idiopathic arthritis, dose may be increased to 248 mg every week.Storage Condition
Actemra IV Infusion 80 mg/4 ml should be stored at room temperature and away from moisture and heat.Volume of Distribution
The volume of distribution of tocilizumab is 53.4 ±18.9 L.Half Life
The half-life of tocilizumab is 8.5 ±3.2 days.Clearance
The clearance of tocilizumab is 4.9 ± 1.6 L/day.See in details version Actemra IV Infusion 80 mg/4 ml also Actemra IV Infusion 80 mg/4 ml in bangla
Social card
Some Frequently Asked Questions About Actemra IV Infusion 80 mg/4 ml
1. What is Actemra IV Infusion 80 mg/4 ml?
Actemra IV Infusion 80 mg/4 ml is a monoclonal antibody that is used to treat various inflammatory conditions, including rheumatoid arthritis, giant cell arteritis, and cytokine release syndrome. It works by blocking the interleukin-6 (IL-6) receptor, which plays a role in inflammation.
2. How does Actemra IV Infusion 80 mg/4 ml work?
Actemra IV Infusion 80 mg/4 ml works by binding to and inhibiting the IL-6 receptor, preventing IL-6 from exerting its inflammatory effects. IL-6 is a cytokine involved in the body's immune response and inflammation, and by blocking this receptor, Actemra IV Infusion 80 mg/4 ml helps reduce inflammation and tissue damage.
3. What are the main uses of Actemra IV Infusion 80 mg/4 ml?
Actemra IV Infusion 80 mg/4 ml is primarily used to treat conditions such as rheumatoid arthritis, giant cell arteritis, systemic juvenile idiopathic arthritis, cytokine release syndrome (CRS), and severe COVID-19-related inflammation.
4. Is Actemra IV Infusion 80 mg/4 ml used for rheumatoid arthritis?
Yes, Actemra IV Infusion 80 mg/4 ml is commonly used for the treatment of moderate to severe rheumatoid arthritis in adults who have not responded adequately to other disease-modifying antirheumatic drugs (DMARDs).
5. Can Actemra IV Infusion 80 mg/4 ml be used for COVID-19?
Actemra IV Infusion 80 mg/4 ml has been used to treat severe COVID-19 in hospitalized patients, particularly those with high levels of inflammation (e.g., elevated C-reactive protein levels). It helps reduce the inflammatory response associated with severe COVID-19 infections.
6. How is Actemra IV Infusion 80 mg/4 ml administered?
Actemra IV Infusion 80 mg/4 ml is typically administered through an intravenous (IV) infusion in a healthcare setting. It can also be given as a subcutaneous injection for certain conditions, such as rheumatoid arthritis.
7. What are the potential side effects of Actemra IV Infusion 80 mg/4 ml?
Common side effects of Actemra IV Infusion 80 mg/4 ml include headache, high blood pressure, liver enzyme elevations, infections, and gastrointestinal issues. Serious side effects can include severe infections, gastrointestinal perforation, and liver damage.
8. Can Actemra IV Infusion 80 mg/4 ml cause an allergic reaction?
Yes, some individuals may experience allergic reactions to Actemra IV Infusion 80 mg/4 ml. Symptoms may include rash, itching, difficulty breathing, and swelling of the face or throat. Immediate medical attention is required for severe allergic reactions.
9. Is Actemra IV Infusion 80 mg/4 ml safe for pregnant women?
Actemra IV Infusion 80 mg/4 ml is categorized as a pregnancy category C drug, meaning that it should only be used during pregnancy if the potential benefits outweigh the risks. Consult your doctor if you are pregnant or planning to become pregnant.
10. Can Actemra IV Infusion 80 mg/4 ml be used during breastfeeding?
It is not known whether Actemra IV Infusion 80 mg/4 ml passes into breast milk. Caution is recommended, and you should discuss with your healthcare provider whether to continue breastfeeding while taking this medication.
11. What is the typical dosage of Actemra IV Infusion 80 mg/4 ml for rheumatoid arthritis?
The typical dosage for rheumatoid arthritis is an initial dose of 4 mg/kg administered via IV infusion every 4 weeks. Depending on the patient's response, the dose may be increased to 8 mg/kg.
12. How long does it take for Actemra IV Infusion 80 mg/4 ml to work?
Patients with rheumatoid arthritis may start to notice improvement in symptoms within 2 to 4 weeks of starting Actemra IV Infusion 80 mg/4 ml. However, the full therapeutic effect may take several months to be evident.
13. Can Actemra IV Infusion 80 mg/4 ml be used for children?
Actemra IV Infusion 80 mg/4 ml is approved for use in children aged 2 years and older for the treatment of systemic juvenile idiopathic arthritis. The dosing is adjusted based on the child's weight and age.
14. What should I do if I miss a dose of Actemra IV Infusion 80 mg/4 ml?
If you miss a dose of Actemra IV Infusion 80 mg/4 ml, contact your healthcare provider for guidance on when to schedule the next dose. It is important to stay on a consistent dosing schedule to maintain the medication's effectiveness.
15. Can Actemra IV Infusion 80 mg/4 ml interact with other medications?
Actemra IV Infusion 80 mg/4 ml can interact with other medications, particularly immunosuppressive drugs and other biologic therapies. It may also interact with certain vaccines and anticoagulants. Inform your healthcare provider about all medications you are taking.
16. What is the risk of infections while taking Actemra IV Infusion 80 mg/4 ml?
Actemra IV Infusion 80 mg/4 ml can increase the risk of infections, including serious infections like tuberculosis, pneumonia, and sepsis. Patients should be monitored for signs of infection and tested for tuberculosis before starting treatment.
17. Can Actemra IV Infusion 80 mg/4 ml cause liver problems?
Yes, Actemra IV Infusion 80 mg/4 ml can cause liver enzyme elevations, and in rare cases, it can lead to liver damage. Liver function should be regularly monitored during treatment.
18. Can Actemra IV Infusion 80 mg/4 ml be used for other autoimmune diseases?
While Actemra IV Infusion 80 mg/4 ml is primarily used for rheumatoid arthritis and systemic juvenile idiopathic arthritis, it is being investigated for other autoimmune diseases, such as lupus and scleroderma. Its use may be considered in certain cases depending on the disease and its severity.
19. How should Actemra IV Infusion 80 mg/4 ml be stored?
Actemra IV Infusion 80 mg/4 ml should be stored in a refrigerator at 2°C to 8°C (36°F to 46°F). It should not be frozen. Keep the medication in its original packaging to protect it from light.
20. Can Actemra IV Infusion 80 mg/4 ml be used for ankylosing spondylitis?
While Actemra IV Infusion 80 mg/4 ml is not specifically approved for ankylosing spondylitis, it may be used off-label in certain cases where other treatments have failed, particularly if the disease is associated with high levels of inflammation.
21. What are the potential risks of taking Actemra IV Infusion 80 mg/4 ml?
The risks of Actemra IV Infusion 80 mg/4 ml include increased susceptibility to infections, liver damage, blood disorders, and gastrointestinal issues. It is important to undergo regular monitoring during treatment.
22. Does Actemra IV Infusion 80 mg/4 ml increase the risk of cancer?
There is a potential increased risk of certain types of cancer, such as lymphoma, in patients taking Actemra IV Infusion 80 mg/4 ml. However, the overall risk is considered low, and this should be discussed with your healthcare provider before starting treatment.
23. Can Actemra IV Infusion 80 mg/4 ml be used in combination with methotrexate?
Yes, Actemra IV Infusion 80 mg/4 ml is often used in combination with methotrexate for the treatment of rheumatoid arthritis. The combination can improve efficacy in managing symptoms and slowing disease progression.
24. How is Actemra IV Infusion 80 mg/4 ml administered for cytokine release syndrome (CRS)?
For cytokine release syndrome, Actemra IV Infusion 80 mg/4 ml is typically administered intravenously as a single dose. Additional doses may be given if the symptoms persist or recur.
25. What are the signs of an allergic reaction to Actemra IV Infusion 80 mg/4 ml?
Signs of an allergic reaction to Actemra IV Infusion 80 mg/4 ml include rash, itching, difficulty breathing, swelling of the face or throat, and dizziness. Seek immediate medical attention if these symptoms occur.
26. Is Actemra IV Infusion 80 mg/4 ml effective for psoriatic arthritis?
While Actemra IV Infusion 80 mg/4 ml is not FDA-approved for psoriatic arthritis, it has been shown to be effective in treating certain cases of psoriatic arthritis, particularly those with high levels of inflammation.
27. Can Actemra IV Infusion 80 mg/4 ml cause high blood pressure?
Yes, Actemra IV Infusion 80 mg/4 ml can cause an increase in blood pressure. Blood pressure should be monitored regularly during treatment, and any significant changes should be addressed with a healthcare provider.
28. What precautions should be taken before starting Actemra IV Infusion 80 mg/4 ml?
Before starting Actemra IV Infusion 80 mg/4 ml, patients should be tested for tuberculosis and other infections. A history of liver disease or blood disorders should also be reviewed. Regular monitoring is required during treatment.
29. Can Actemra IV Infusion 80 mg/4 ml be used in elderly patients?
Actemra IV Infusion 80 mg/4 ml can be used in elderly patients, but they may be at a higher risk for side effects, particularly infections and liver problems. Close monitoring is necessary during treatment.
30. What is the role of Actemra IV Infusion 80 mg/4 ml in treating giant cell arteritis?
Actemra IV Infusion 80 mg/4 ml is used to treat giant cell arteritis by reducing inflammation in the arteries, which can help prevent complications such as vision loss or stroke.
31. Is Actemra IV Infusion 80 mg/4 ml safe for people with a history of tuberculosis?
Patients with a history of tuberculosis should be carefully evaluated before starting Actemra IV Infusion 80 mg/4 ml. The drug can increase the risk of reactivating latent tuberculosis, so appropriate testing and preventive treatment may be required.
32. Can Actemra IV Infusion 80 mg/4 ml be used for systemic lupus erythematosus (SLE)?
Actemra IV Infusion 80 mg/4 ml is not FDA-approved for the treatment of lupus, but it may be considered for off-label use in severe cases that involve significant inflammation and high IL-6 levels.
33. How does Actemra IV Infusion 80 mg/4 ml affect cholesterol levels?
Actemra IV Infusion 80 mg/4 ml can lead to increases in cholesterol levels, particularly LDL cholesterol. Regular monitoring of lipid levels is recommended during treatment.
34. Can Actemra IV Infusion 80 mg/4 ml be used to treat inflammation in inflammatory bowel disease (IBD)?
While Actemra IV Infusion 80 mg/4 ml is not typically used for IBD, its role in reducing inflammation may be explored in specific cases where other treatments have not been effective.
35. Does Actemra IV Infusion 80 mg/4 ml affect the immune system?
Yes, Actemra IV Infusion 80 mg/4 ml suppresses certain aspects of the immune system by inhibiting IL-6, which can increase the risk of infections and reduce the body's ability to fight off diseases.
36. Can Actemra IV Infusion 80 mg/4 ml cause weight gain?
Weight gain is not a common side effect of Actemra IV Infusion 80 mg/4 ml, but some individuals may experience fluid retention, which could lead to mild weight gain.
37. Can Actemra IV Infusion 80 mg/4 ml be used for vasculitis?
Actemra IV Infusion 80 mg/4 ml has shown effectiveness in treating certain types of vasculitis, especially those associated with elevated IL-6 levels. It may be used off-label for this purpose under careful medical supervision.
38. How does Actemra IV Infusion 80 mg/4 ml affect kidney function?
Actemra IV Infusion 80 mg/4 ml can affect kidney function in some patients, particularly those with pre-existing kidney issues. Kidney function should be monitored during treatment, and any significant changes should be addressed promptly.
39. Can Actemra IV Infusion 80 mg/4 ml be used to treat rheumatoid arthritis in people with liver disease?
Actemra IV Infusion 80 mg/4 ml should be used with caution in people with liver disease, as it can cause liver enzyme elevations. Close monitoring of liver function is necessary during treatment.
40. What should I do if I experience severe side effects from Actemra IV Infusion 80 mg/4 ml?
If you experience severe side effects, such as trouble breathing, swelling of the face, or signs of an infection, seek immediate medical attention. Your doctor may need to adjust your dosage or discontinue treatment.
41. Can Actemra IV Infusion 80 mg/4 ml be used for osteoarthritis?
Actemra IV Infusion 80 mg/4 ml is not typically used for osteoarthritis, as the condition involves different mechanisms of inflammation. However, it may be considered in certain cases with significant inflammatory components.
42. How does Actemra IV Infusion 80 mg/4 ml compare to other biologic therapies?
Actemra IV Infusion 80 mg/4 ml is one of several biologic therapies used to treat inflammatory diseases. It targets IL-6, while other biologics may target different molecules, such as TNF-alpha (e.g., etanercept, infliximab). The choice of biologic depends on the patient's condition and response to treatment.
43. How long can Actemra IV Infusion 80 mg/4 ml be used for rheumatoid arthritis?
Actemra IV Infusion 80 mg/4 ml can be used long-term for rheumatoid arthritis, as long as the patient continues to respond well to the medication and does not experience severe side effects. Regular monitoring is required during long-term use.
44. Can Actemra IV Infusion 80 mg/4 ml cause hair loss?
Hair loss is not a common side effect of Actemra IV Infusion 80 mg/4 ml, but some patients may experience hair thinning or changes in hair texture due to the effects of the medication.
45. Can Actemra IV Infusion 80 mg/4 ml be used for multiple sclerosis?
Actemra IV Infusion 80 mg/4 ml is not approved for the treatment of multiple sclerosis (MS), but its potential use in MS may be explored in clinical trials, particularly for its effects on inflammation.
46. How does Actemra IV Infusion 80 mg/4 ml affect blood cell counts?
Actemra IV Infusion 80 mg/4 ml can cause changes in blood cell counts, including a decrease in white blood cells, red blood cells, and platelets. Regular blood tests are needed to monitor these levels during treatment.
47. Can Actemra IV Infusion 80 mg/4 ml cause diarrhea?
Diarrhea is a potential side effect of Actemra IV Infusion 80 mg/4 ml, though it is not very common. Patients who experience persistent or severe diarrhea should contact their doctor.
48. Can Actemra IV Infusion 80 mg/4 ml be used for sarcoidosis?
Actemra IV Infusion 80 mg/4 ml is not typically used for sarcoidosis, but it may be considered off-label in certain cases with significant inflammation or poor response to other treatments.
49. What are the benefits of Actemra IV Infusion 80 mg/4 ml?
The main benefits of Actemra IV Infusion 80 mg/4 ml include its ability to reduce inflammation, improve joint function, and decrease pain and damage in conditions like rheumatoid arthritis and systemic juvenile idiopathic arthritis.
50. How should I prepare for a Actemra IV Infusion 80 mg/4 ml infusion?
Before a Actemra IV Infusion 80 mg/4 ml infusion, you will be monitored for any signs of allergic reactions. It is also essential to ensure that you do not have active infections or a history of tuberculosis. Make sure to inform your healthcare provider of any health changes before starting treatment.
